-
GYG delivers and expects to exceed FY25 forecasts
Roger Montgomery
February 25, 2025
Guzman y Gomez (ASX:GYG) has reported its half-year results, exceeding the market’s expectations for revenue by two per cent but missed the markets earnings before interest, taxes, depreciation and amortisation (EBITDA) forecasts by four per cent. The market’s negative reaction to the results suggests the share price had moved too far ahead of operational milestones. Continue…
by Roger Montgomery Posted in Companies, Small Caps.
- save this article
- POSTED IN Companies, Small Caps.
-
ResMed’s half-year FY25 results: solid growth & expanding opportunities
Roger Montgomery
February 4, 2025
ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future growth opportunities. Continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like.
-
Could Trump’s ideology, backed by primary school maths, cause a market meltdown?
Roger Montgomery
April 5, 2025
Could it be possible that the markets are tumbling because Trump and his team can’t add, or worse, lied to hide a warped ideology?
President Donald Trump’s administration has rolled out sweeping “reciprocal tariffs” targeting over 180 countries in a move that has sent shockwaves through global financial markets and trade networks. Announced with typical Trump fanfare in the White House Rose Garden on 4 April 2025, Trump wielded a chart (Table 1) to underscore his point, claiming his measures would level the playing field and end decades of the U.S. being “ripped off” by its trading partners. Continue…
by Roger Montgomery Posted in Market commentary.
- 6 Comments
- save this article
- 6
- POSTED IN Market commentary.
-
Could Oval Office madness be part of a bigger plan?
Roger Montgomery
March 6, 2025
The U.S. is a flawed country, but many believe, as the New York Times’s David Brooks noted, is fundamentally a force for good. Citing the Marshall Plan, the defeat of fascism, and the defeat of the Soviet Union, as examples, and acknowledging Iraq and Vietnam, as mistakes of stupidity, naïveté and arrogance, Brooks believes the U.S. has always been well-intentioned. Continue…
by Roger Montgomery Posted in Economics.
- 1 Comments
- save this article
- 1
- POSTED IN Economics.
-
EVs still on the brakes
Roger Montgomery
March 13, 2025
For years, we’ve been fed a whimsical story that battery electric vehicles (BEVs) are on an unstoppable march to dominate our roads – spurred on by ambitious government targets, subsidies, that hydrocarbons are evil, and a steady drumbeat of headlines proclaiming that “electric is the future.” Continue…
by Roger Montgomery Posted in Manufacturing.
- save this article
- POSTED IN Manufacturing.
-
Half-yearly insights: bite sized summaries from the week
Roger Montgomery
February 28, 2025
With reporting season coming to an end, companies listed on the Australian Securities Exchange (ASX) have released their half-year results, offering insights into their financial performance and strategic direction. I have summarised the results of seven companies, highlighting key earnings surprises, market reactions, and potential opportunities for investors. Continue…
by Roger Montgomery Posted in Companies.
- save this article
- POSTED IN Companies.
-
The stock market’s stagnant start to 2025
Roger Montgomery
March 5, 2025
Two months into 2025 and a palpable sense of disquiet seems to have settled over equity markets. Far from the jubilant ascents of the previous two years, the stock market’s performance this year has been a sobering affair, marked by a notable absence of vigour. Continue…
by Roger Montgomery Posted in Technology & Telecommunications.
- save this article
- POSTED IN Technology & Telecommunications.
-
CSL’s mixed half-year: plasma strength offsets vaccine weakness, bright outlook maintained
Roger Montgomery
February 18, 2025
CSL (ASX:CSL) has posted its half-year results, delivering results that are best described as mixed. At the headline level, revenue climbed around five per cent, while net profit after tax and amortisation (NPATA) also nudged upward in the low single digits. Beneath these top-line numbers, the company reported a robust rebound in plasma collections, which was offset by weaker sales of its Seqirus influenza vaccines. Despite these mixed signals, management has reaffirmed guidance for FY25, projecting 10-13 per cent NPATA earnings per share (EPS) growth and a five to seven per cent lift in revenue. Continue…
by Roger Montgomery Posted in Companies, Stocks We Like.
- save this article
- POSTED IN Companies, Stocks We Like.
-
Nick Scali reports strong 1H25 results
Roger Montgomery
February 12, 2025
Nick Scali Limited (ASX:NCK), a holding in the Montgomery Small Companies Fund has released its half-year 2025 (1H25) results. Despite the mixed headline picture, Nick Scali’s 1H25 results outperformed consensus estimates. Continue…
by Roger Montgomery Posted in Companies, Small Caps, Stocks We Like.
- save this article
- POSTED IN Companies, Small Caps, Stocks We Like.
-
Trump’s tariff gambit – reshaping global trade or stirring economic chaos?
Roger Montgomery
March 21, 2025
U.S. President Donald Trump has embarked on what some say is a belligerent and dangerous mission to upend and reshape the international economic and competitive landscape through a series of aggressive tariff policy changes. His approach which is characterised by sudden shifts and strategic reversals, aims to bolster American manufacturing and fill government coffers. Continue…
by Roger Montgomery Posted in Global markets, Market commentary.
- save this article
- POSTED IN Global markets, Market commentary.
Investing in gold – Should you be bullish or bearish? LISTEN NOW